Glomerulonephritis

Glomerulonephritis (GN) is a group of renal diseases characterized by inflammation of the glomeruli, the microscopic filtering units of the kidneys. GN can present as an acute, self-limiting illness or a chronic, progressive disease leading to permanent renal impairment. It manifests clinically as either nephritic syndrome (hematuria, hypertension, mild-to-moderate proteinuria, and oliguria) or nephrotic syndrome (heavy proteinuria >3.5 g/day, hypoalbuminemia, hyperlipidemia, and severe edema).

The etiology of glomerulonephritis is multifactorial, categorized into primary (restricted to the kidneys) and secondary (associated with systemic diseases):
Infections: Post-streptococcal glomerulonephritis (PSGN) following group A beta-hemolytic Streptococcus* infection; viral infections (Hepatitis B, Hepatitis C, HIV); infective endocarditis.

• Autoimmune Diseases: Systemic lupus erythematosus (SLE), IgA nephropathy (Berger's disease), anti-glomerular basement membrane (anti-GBM) disease (Goodpasture’s syndrome), and ANCA-associated vasculitis (e.g., granulomatosis with polyangiitis).


• Genetic Factors: Hereditary nephritis (Alport syndrome).


• Idiopathic: Focal segmental glomerulosclerosis (FSGS), membranous nephropathy, and minimal change disease.

The primary mechanism driving glomerulonephritis is immunologically mediated injury. Immune complexes (antigen-antibody units) deposit within the glomerular structures—including the mesangium, subendothelial, or subepithelial spaces—or antibodies bind directly to glomerular basement membrane (GBM) antigens. These deposits trigger the complement cascade and attract inflammatory cells (neutrophils, macrophages, and T-lymphocytes). The subsequent release of inflammatory cytokines, reactive oxygen species, and lysosomal enzymes disrupts the glomerular filtration barrier. This injury alters capillary permeability, leading to the leakage of red blood cells (causing hematuria and RBC casts) and proteins (causing proteinuria) into the urinary space, while simultaneously reducing the overall glomerular filtration rate (GFR).

Glomerulonephritis is a leading cause of end-stage renal disease (ESRD) worldwide.

• Age and Gender: IgA nephropathy is the most common primary GN globally, predominantly affecting young males in their second and third decades. PSGN is more common in children aged 2 to

1. Lupus nephritis is highly prevalent in females of childbearing age.

• Prevalence: GN accounts for approximately 10% to 15% of all ESRD cases in Western countries.

• Recent group A streptococcal skin or pharyngeal infection
• Pre-existing autoimmune disorders (SLE, rheumatoid arthritis, vasculitis)
• Chronic viral infections (Hepatitis B, Hepatitis C, HIV)
• Family history of kidney disease or Alport syndrome
• Exposure to nephrotoxic drugs or organic solvents

• Vital Signs: Elevated blood pressure (hypertension); tachypnea in cases of fluid overload.
• Inspection: Periorbital edema, bilateral pitting edema of the lower extremities, jugular venous distention (JVD).
• Auscultation: Bilateral basilar crackles (rales) indicating pulmonary edema; a S3 gallop may be present in severe fluid overload.

• A. Clinical Assessment: Comprehensive history focusing on recent infections, family history, and drug exposure.
• B. Laboratory Testing: Urinalysis, serum chemistry (creatinine, BUN, electrolytes), and immunological markers.
• C. Imaging Studies: Renal ultrasound to evaluate kidney size and rule out structural obstruction.
• D. Functional Tests: 24-hour urine collection or spot protein-to-creatinine ratio (UPCR) to quantify proteinuria; eGFR calculation.
• E. Biopsy Findings: Renal biopsy (light, immunofluorescence, and electron microscopy) remains the gold standard to establish histopathological diagnosis.
• F. Genetic Testing: Indicated in cases of suspected Alport syndrome.
• G. Differential Diagnosis: Acute tubular necrosis (ATN), acute interstitial nephritis (AIN), prerenal azotemia.

Renal Ultrasound: Purpose: To evaluate the size, shape, and echogenicity of the kidneys and to rule out urinary tract obstruction. Typical Findings: In acute GN, kidneys are normal-sized or slightly enlarged and echogenic. In chronic GN, kidneys appear small, shrunken, and thin-cortexed. Clinical Importance: Essential step before performing a renal biopsy to ensure safety and check for structural contraindications.

• Acute Tubular Necrosis (ATN): Differentiated by the presence of muddy brown granular casts, absence of significant proteinuria, and lack of RBC casts.
• Acute Interstitial Nephritis (AIN): Characterized by eosinophiluria, sterile pyuria, skin rash, and an association with offending medications (e.g., NSAIDs, antibiotics).
• Prerenal Azotemia: Rapidly reverses with volume resuscitation; urine sediment is typically bland with low fractional excretion of sodium (FeNa <1%).

• Acute Kidney Injury (AKI)
• Chronic Kidney Disease (CKD) progressing to ESRD
• Nephrotic Syndrome
• Severe hypertension and hypertensive crises
• Congestive heart failure and pulmonary edema

• Acute Post-Streptococcal GN: Excellent prognosis in children, with over 95% achieving complete recovery. Prognosis is less favorable in adults, where chronic renal impairment may persist.
• Rapidly Progressive GN (RPGN): Poor prognosis without immediate aggressive therapy; can progress to ESRD within weeks.
• Chronic GN: Slowly progressive, often leading to gradual renal decline over decades, necessitating renal replacement therapy.

• Rapid and complete antibiotic treatment of streptococcal infections.
• Careful monitoring and strict blood pressure control in patients with systemic autoimmune diseases.
• Avoiding nephrotoxic medications (e.g., chronic NSAID use).

The following homeopathic remedies have been historically indicated for symptoms associated with Glomerulonephritis. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 Advanced Kidney & Renal Function Analyzer

Comprehensive nephrology panel. Calculates eGFR (CKD-EPI 2021 formula), CKD Stage, BUN/Creatinine Ratio, and Creatinine Clearance (Cockcroft-Gault) from a single lab panel.